Previous 10 | Next 10 |
The WSJ reports that the coronavirus responsible for the current outbreak in China, mainly in the city of Wuhan, appears less virulent than the virus responsible for the SARS outbreak in 2003. More news on: Moderna, Inc., NanoViricides, Inc., Novavax, Inc., Healthcare stocks news, Stocks...
Later today, the U.S. Centers for Disease Control and Prevention will brief the media on the coronavirus outbreak in China that has stricken 291 people and killed six, mostly in the city of Wuhan in Hubei province. More news on: NanoViricides, Inc., Novavax, Inc., Inovio Pharmaceuticals, I...
Applied Genetic Technologies (NASDAQ: AGTC ) +53% on positive XLRP data . More news on: Applied Genetic Technologies Corporation, VBI Vaccines Inc., The Peck Company Holdings, Inc., Stocks on the move, Read more ...
Have you ever traded penny stocks or are you just getting your feet wet with these low priced stocks? No matter what kind of experience you have, it’s a safe bet that you know these types of stocks are risky. But that doesn’t mean they aren’t profitable. In fact, if you...
The FDA accepts for revie w Nabriva Therapeutics' (NASDAQ: NBRV ) resubmitted marketing application for Contepo (fosfomycin) for the treatment of complicated urinary tract infections. The agency's action date is June 19. More news on: Nabriva Therapeutics plc, Healthcare stocks news, Stoc...
DUBLIN, Ireland, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections, announced that the U.S. Food and Drug Administration (FDA) has...
Gainers: Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...
Stealth BioTherapeutics (NASDAQ: MITO ) -56% after elamipretide flunks late-stage PMM study. More news on: Stealth BioTherapeutics Corp, Valeritas Holdings, Inc., Abeona Therapeutics Inc., Stocks on the move, Read more ...
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has ente...
-Nabriva anticipates a six-month review period by the Food and Drug Administration -CONTEPO is a potential first-in-class intravenous antibiotic in U.S. for the treatment of complicated urinary tract infections DUBLIN, Ireland, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc...
News, Short Squeeze, Breakout and More Instantly...
Nabriva Therapeutics plc Company Name:
NBRV Stock Symbol:
NASDAQ Market:
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV) today announced that, after an assessment ...
- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Na...
- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya Capital As Strategic Advisor - - Conference call today at 4:30 p.m. Eastern Time - DUBLIN, Ireland, ...